solo-1: olaparib or placebo for patients with newly diagnosed brca-mutated advanced ovarian cancer
Published 3 years ago • 625 plays • Length 3:24Download video MP4
Download video MP3
Similar videos
-
10:34
solo1: maintenance olaparib in advanced brca ovarian cancer
-
3:58
solo-1: practice changing data on olaparib for ovarian cancer
-
7:38
results from phiii solo1 trial in brcam ovarian cancer
-
7:28
comment on solo1 for advanced ovarian cancer
-
1:57
7-year os from solo1: sustained benefit with maintenance olaparib
-
5:48
solo1: 7-year follow-up highlights the value of maintenance olaparib
-
4:14
olaparib continues to show positive results in advanced ovarian cancer - 7 year data
-
4:44
expert report on survival data from pivotal trials with parp inhibitors for brca-mut. ovarian cancer
-
6:03
olaparib maintenance for recurrent ovarian cancer
-
3:37
selecting patients to be treated with maintenance olaparib in the paola-1 trial
-
6:18
value of olaparib in brca-mutated advanced ovarian cancer
-
3:42
comment on solo1 trial
-
4:54
impact of solo-1 on advanced ovarian cancer management
-
5:25
solo-1: frontline olaparib maintenance therapy in ovarian cancer
-
3:38
solo-1: practice changing results for advanced ovarian cancer
-
3:50
olaparib beneficial for brca-mutated her2-negative breast cancer
-
8:07
highly anticipated data from the solo-1 trial
-
2:19
phase iii results of olaparib for brca breast cancer
-
5:32
parp inhibitor olaparib added to bevacizumab benefits women with ovarian cancer with and without...